News

The National Institute for Health and Care Excellence3d
Final draft guidance finds benefits of 2 Alzheimer’s treatments remain too small to justify the additional costs to the NHS
The benefits of Alzheimer’s treatments donanemab and lecanemab remain too small to justify the additional costs ...
National Institute for Health and Care Excellence1mon
New guideline will help cut falls and related hospital admissions for older and at-risk people
As well as making recommendations on hazards in a person’s home, the updated guidance published today also covers residential care homes, hospitals and other healthcare settings in the community, for ...
The National Institute for Health and Care Excellence12d
Updated guideline to increase access to treatments for early-stage chronic heart failure could reduce deaths and hospital admissions by thousands
Around 3,000 deaths and 5,500 hospital admissions in England caused by chronic heart failure could be prevented each year following our updated draft guideline on medical treatment of the disease.
The National Institute for Health and Care Excellence9d
NICE leads the way in approving breakthrough treatment for multiple myeloma
Cookies are files saved on your phone, tablet or computer when you visit a website. We use cookies to store information about how you use the NICE website and services, such as the pages you visit.
The National Institute for Health and Care Excellence6d
‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes
Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.
National Institute for Health and Care Excellence3d
Topical antimicrobial dressings for locally infected leg ulcers: Late stage assessment
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
National Institute for Health and Care Excellence3d
Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer
There is a simple discount patient access scheme for atezolizumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact welwyn.rx_bdop ...
National Institute for Health and Care Excellence4d
Spesolimab for treating generalised pustular psoriasis flares
There is a simple discount patient access scheme for spesolimab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
National Institute for Health and Care Excellence13d
PillCam COLON 2 for investigation of the colon through direct visualisation
Date Update 09 June 2025 The resolution start date for this topic has been delayed. The revised timeline for the evaluation will be available on the topic webpage in due course.
National Institute for Health and Care Excellence1mon
Highly specialised technologies evaluation committee (HSTEC) meeting
The meeting will take place via Zoom, a secure web conferencing tool. The meeting will run from 9:00am to 1:00pm, although this may be subject to change. The joining link and time for the topic and ...
National Institute for Health and Care Excellence11d
Guidance and quality standards awaiting development
Venetoclax with azacitidine for treating acute myeloid leukaemia before and after an allogeneic stem cell transplant [ID6468] Technology appraisal guidance Venetoclax with ibrutinib for treating ...